Clinical Trial: Study on the Mechanism of Paeoniflorin Alleviating Oxidative Stress in Cerebral Ischemia-Reperfusion Injury via the Smurf1/Keap1 Pathway (China)

Posted On: 2026-09-16

China, Sept. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Mechanism of Paeoniflorin Alleviating Oxidative Stress in Cerebral Ischemia-Reperfusion Injury via the Smurf1/Keap1 Pathway'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132538

Registration Time: 2026/09/15

Type: Observational study

Primary Sponsor: Suzhou Hospital of Integrated Traditional Chinese and Western Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333599

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Study on the Mechanism of Paeoniflorin Alleviating Oxidative Stress in Cerebral Ischemia-Reperfusion Injury via the Smurf1/Keap1 Pathway (China)